Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Glioblastoma Multiforme”

936 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 936 results

Testing effectiveness (Phase 2)Study completedNCT02844439
What this trial is testing

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaBrain Tumor
Kadmon Corporation, LLC 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03233152
What this trial is testing

A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma.

Who this might be right for
Glioblastoma
Universitair Ziekenhuis Brussel 110
Early research (Phase 1)Study completedNCT02859857
What this trial is testing

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Bexion Pharmaceuticals, Inc. 86
Testing effectiveness (Phase 2)UnknownNCT00114309
What this trial is testing

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+3 more
TransMolecular 66
Testing effectiveness (Phase 2)Study completedNCT00041587
What this trial is testing

Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
INSYS Therapeutics Inc 80
Early research (Phase 1)Looking for participantsNCT04323046
What this trial is testing

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioblastoma+3 more
Sabine Mueller, MD, PhD 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05902169
What this trial is testing

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Who this might be right for
GlioblastomaRecurrent GlioblastomaGBM
CarThera 560
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Testing effectiveness (Phase 2)Looking for participantsNCT04765098
What this trial is testing

Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Who this might be right for
Glioblastoma Multiforme
AHS Cancer Control Alberta 60
Early research (Phase 1)Study completedNCT05362409
What this trial is testing

Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma

Who this might be right for
High Grade Glioma
Alpheus Medical, Inc. 22
Not applicableStudy completedNCT04846257
What this trial is testing

Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence

Who this might be right for
Glioblastoma
Egyptian Medical Syndicate 260
Testing effectiveness (Phase 2)Study completedNCT02490800
What this trial is testing

Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma

Who this might be right for
Neoplasms
Basilea Pharmaceutica 72
Early research (Phase 1)WithdrawnNCT00734864
What this trial is testing

Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
Annick Desjardins
Large-scale testing (Phase 3)Looking for participantsNCT03970447
What this trial is testing

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Global Coalition for Adaptive Research 2,250
Testing effectiveness (Phase 2)Study completedNCT00800917
What this trial is testing

Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Rigshospitalet, Denmark 12
Very early researchActive Not RecruitingNCT03893487
What this trial is testing

Fimepinostat in Treating Brain Tumors in Children and Young Adults

Who this might be right for
Diffuse Intrinsic Pontine GliomaRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma+2 more
Sabine Mueller, MD, PhD 30
Not applicableUnknownNCT02119338
What this trial is testing

5-ALA in Recurrent Glioma

Who this might be right for
Glioma
St. Joseph's Hospital and Medical Center, Phoenix 60
Very early researchStudy completedNCT00864864
What this trial is testing

Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma

Who this might be right for
GlioblastomaBrain Tumor
Massachusetts General Hospital 8
Testing effectiveness (Phase 2)WithdrawnNCT00984438
What this trial is testing

Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Cincinnati
Not applicableStudy completedNCT00499798
What this trial is testing

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility
Wake Forest University Health Sciences 16
Load More Results